Delivery Order SPE2DB22D3019-SPE2DB25FK2YQ
Award Date
1/7/25
Potential Completion Date
1/29/25
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is for the delivery of ENVARSUS XR 1 MG TABLET 100S, a specialty pharmaceutical product, with a potential value of $2,026.85 and a performance period through March 15, 2024. This delivery order is issued under a larger, single-award indefinite...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,339.52, is for the supply of ENVARSUS XR 0.75 MG TABLET 30S, a medication used in transplant patient care. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a leading global pharmaceutical sourcing and distribution company. The contract is for the delivery of ENVARSUS XR 1 MG TABLET 100S, with a ceiling value of $1,621.48 and a performance period through April 9, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,013.48 firm fixed-price delivery order covers the supply of ENVARSUS XR 4 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of January 15, 2025.
Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a $1,615.33 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of ENVARSUS XR 4 MG TABLET 100S. The contract has an ultimate completion date of September 19, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these prescription medications to support military treatment facilities and other federal healthcare providers. This delivery order is part of a larger Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The $1,677.52 firm fixed-price contract is for the supply of ENVARSUS XR 1 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of December 23, 2024 and is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,933.80, is for the delivery of ENVARSUS XR 0.75 MG TABLET 100S, a pharmaceutical product. The contract type is a Delivery Order with a Firm Fixed Price pricing type. The ultimate completion date is January 30, 2025. This award is associated with a larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,645.68 firm fixed-price contract is for the supply of ENVARSUS XR 0.75 MG Tablets. This contract has a period of performance through February 17, 2023.
Amerisourcebergen is a for-profit organization and holds significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,103.64 firm fixed-price delivery order is for the supply of ENVARSUS XR 0.75 MG TABLET 30S, a specialty pharmaceutical product.
The contract has an ultimate completion date of November 26, 2024 and was awarded on November 4, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of Amerisourcebergen Corporation. The $1,216.11 order is for the pharmaceutical product ENVARSUS XR 1 MG TABLET 100S, with a completion date of March 7, 2024.
Amerisourcebergen Drug Corp is the prime contractor on an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00...